Abstract 6932: BCG045: A first-in-class bispecific ADC targeting TROP2 and MUC1 demonstrates promising tumor efficacy and potentially reduced toxicity in preclinical studies
Year: 2026
Type: conference-abstract
Source: Cancer Research
Authors: Jeremy Lee, Yifu Zhang, Chengzhang Shang, Yi Yang
Language: English
Subfield: Radiology, Nuclear Medicine and Imaging
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7148718187
Cites:
Cited by:
Related to: